Cetrorelix
Fast-acting GnRH antagonist that stops premature ovulation during IVF cycles
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
0.25 – 3 mg
Compound profile
Scientific & efficacy data
Hormone Support
Peptide profile
Strong human trials
Cetrorelix
0.25 mg · Once daily
Molecular formula
C70H92ClN17O14
- Mol. weight
- 1431.06 Da
- CAS number
- 100885-89-0
- PubChem
- 25074887
- Developed · 1993
- Aeterna Zentaris Research Team
Aeterna Zentaris (formerly Arpida/Zentaris)
Amino acid sequence
Ac-D-2-Nal-D-4-Cl-Phe-D-3-Pal-Ser-Tyr-D-Cit-Leu-Lys-Pro-D-Ala-NH2Ovulation Control
Cetrorelix gives you and your doctor almost perfect control over when ovulation happens, which is the whole point of IVF.
Cycle Flexibility
You can start cetrorelix mid-cycle or adjust dosing based on how your body responds, making treatment adaptable to your specific needs.
Side Effect Profile
Most women tolerate cetrorelix really well compared to older hormone treatments. Injection site redness is the main complaint, not serious symptoms.
Dosing
How much do I take?
0.25 – 3 mg
0.25 – 3 mg
Covers all 2 documented dose levels · timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for planning ivf with precise ovulation timing & preventing premature egg release during controlled stimulation
Best for
Planning IVF with precise ovulation timing
Cetrorelix is particularly well-suited for individuals focused on planning ivf with precise ovulation timing. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Preventing premature egg release during controlled stimulation
Cetrorelix is particularly well-suited for individuals focused on preventing premature egg release during controlled stimulation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Managing polycystic ovary syndrome (PCOS) during fertility treatment
Cetrorelix is particularly well-suited for individuals focused on managing polycystic ovary syndrome (pcos) during fertility treatment. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Cetrorelix with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Subcutaneous injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
13 common side effects · 3 serious
Cetrorelix is an FDA-approved GnRH antagonist used exclusively in assisted reproductive technology with proven safety in short-term reproductive cycles.
Unlike GnRH agonists, cetrorelix lacks the initial testosterone flare, making it well-tolerated for ovarian stimulation. Primary side effects are mild and local—injection site reactions (erythema, bruising) occur in 10-20% of patients.
No systemic bone loss, cardiovascular complications, or serious adverse events have been reported in the reproductive context where treatment duration is limited (typically 7-10 days). The short treatment window in IVF protocols minimizes long-term safety concerns.
Hypersensitivity reactions are rare but possible.
Cetrorelix was studied through Phase 3 clinical trials specifically for IVF applications, with large multicenter randomized trials demonstrating safety and efficacy. Regulatory approval in the U.S.
and Europe was based on comprehensive Phase 2 and Phase 3 data in infertile patients undergoing controlled ovarian hyperstimulation. Long-term safety data beyond the typical 1-2 week treatment cycle is limited because the drug is not used for chronic applications.
Common side effects · experienced by some users
Injection site reactions (redness, itching, swelling)
Injection site reactions (redness, itching, swelling)
Management: Consult your healthcare provider for guidance.
Headache
Headache
Management: Consult your healthcare provider for guidance.
Nausea
Nausea
Management: Consult your healthcare provider for guidance.
Mild abdominal discomfort
Mild abdominal discomfort
Management: Consult your healthcare provider for guidance.
Dizziness
Dizziness
Management: Consult your healthcare provider for guidance.
Allergic reactions (rash, difficulty breathing)
Allergic reactions (rash, difficulty breathing)
Management: Consult your healthcare provider for guidance.
Ovarian hyperstimulation syndrome (OHSS) if used with other fertility drugs
Ovarian hyperstimulation syndrome (OHSS) if used with other fertility drugs
Management: Consult your healthcare provider for guidance.
Ovarian cysts
Ovarian cysts
Management: Consult your healthcare provider for guidance.
Vaginal bleeding
Vaginal bleeding
Management: Consult your healthcare provider for guidance.
Mood changes
Mood changes
Management: Consult your healthcare provider for guidance.
Liver enzyme changes
Liver enzyme changes
Management: Consult your healthcare provider for guidance.
Pelvic pain
Pelvic pain
Management: Consult your healthcare provider for guidance.
Severe allergic reaction
Severe allergic reaction
Management: Consult your healthcare provider for guidance.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Cetrorelix
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Cetrorelix should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- Safe:Follicle Stimulating Hormone (FSH) — FSH stimulates your ovaries to grow multiple follicles while cetrorelix prevents premature ovulation—they work together perfectly.
- Safe:Human Menopausal Gonadotropin (hMG) — This combination hormone provides both FSH and LH stimulation while cetrorelix blocks the unwanted LH surge.
- Safe:Progesterone — After egg retrieval, progesterone prepares your uterus for implantation while cetrorelix has done its job preventing ovulation.
With medications
- Caution:GnRH Agonists (Lupron, Buserelin) — Both affect GnRH signaling. Using both together would be like fighting yourself—they work against each other.
- Caution:Certain hormone contraceptives — Birth control pills taken right before cetrorelix can interfere with how well the antagonist works. Your doctor will tell you when to stop birth control.
With supplements
- Safe:Multivitamins — Generally safe to take alongside Cetrorelix. Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know it's working?
Strong human trials · first signs within 1-2 hours
Evidence level
Strong human trials
(Phase 3 or FDA approved)
Regulatory status
FDA approved for this use
Onset of effects
Moderate
(1-2 weeks)
How it works
Cetrorelix immediately blocks GnRH receptors to prevent premature ovulation during fertility treatment.
Unlike older hormone drugs that work slowly, cetrorelix stops the LH surge within hours, giving doctors exact control over egg maturation timing. This precision dramatically improves IVF success rates and reduces dangerous ovarian hyperstimulation.
The deeper mechanism
Cetrorelix is a synthetic GnRH antagonist decapeptide with N-terminal acetylation and substitutions including D-2-naphthylalanine and chloro-D-phenylalanine that provide high-affinity competitive antagonism at pituitary GnRH receptors.
Unlike GnRH agonists, cetrorelix produces immediate suppression without prior stimulation or flare, achieving LH suppression within 1-2 hours of administration.
During controlled ovarian hyperstimulation, cetrorelix prevents the spontaneous LH surge that would trigger ovulation before egg retrieval.
The peptide is given via daily subcutaneous injection during the stimulation cycle, with reversible receptor blockade that clears within 24 hours of the final dose.
This precise, immediate control enables synchronized egg maturation and retrieval, optimizing IVF success by allowing optimal timing of hCG trigger injection.
What to expect
Within 1-2 hours
What you might notice
- Peak blood levels reached
- The medication is absorbed quickly under the skin and spreads through your bloodstream.
What's normal
- Initial response to Cetrorelix is beginning at the cellular level
- Different individuals experience Cetrorelix's onset at different rates
- Transient systemic effects from initial Cetrorelix exposure are common
What's next
- Maintain consistent Cetrorelix administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
Within 8 hours
What you might notice
- LH surge prevention begins
- Your pituitary stops responding to your body's natural GnRH signals.
What's normal
- Cetrorelix is achieving sufficient receptor engagement
- Initial mechanism of Cetrorelix is taking effect
- Early transient effects from Cetrorelix administration are resolving
What's next
- Maintain consistent Cetrorelix administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
24-48 hours after last dose
What you might notice
- Normal hormone signaling returns
- Once cetrorelix is out of your system, your pituitary can respond to GnRH again.
What's normal
- Cetrorelix is achieving sufficient receptor engagement
- Initial mechanism of Cetrorelix is taking effect
- Early transient effects from Cetrorelix administration are resolving
What's next
- Maintain consistent Cetrorelix administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
3-5 days into treatment
What you might notice
- Eggs are ready for retrieval
- During this time, your eggs are maturing while cetrorelix prevents them from being released too early.
What's normal
- Cetrorelix response patterns are emerging
- Initial Cetrorelix response is consistent with mechanism expectations
- Early tolerance development to Cetrorelix is not expected
What's next
- Assess whether Cetrorelix response aligns with expectations
- Plan next steps based on initial Cetrorelix tolerance and response
- Establish baseline monitoring for Cetrorelix response tracking
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to Cetrorelix over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Clinical trials
Tested in people
125 registered studies, 11 still enrolling.
By phase
A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.
What kind of research
About 21,563 people took part in the studies that actually administered Cetrorelix. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.
Most recent
Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist and Progestin-primed Ovarian Stimulation (PPOS) in Controlled Ovarian Stimulation for in Vitro Fertilization: a Prospective Comparative Observational Study
Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)
Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI
Ahmed Saad
Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A
ShangHai Ji Ai Genetics & IVF Institute
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when Cetrorelix is named as an intervention; studies that only mention it in passing are not.
Questions
Frequently asked
How is cetrorelix different from birth control pills?
Birth control pills use hormones to prevent ovulation, but they work over weeks. Cetrorelix is a peptide antagonist that works within hours by blocking hormone receptors. It's much faster and more precise, which is why it's perfect for IVF where timing is everything.
Will cetrorelix hurt my fertility long-term?
No. Cetrorelix is temporary—it only blocks GnRH while you're using it. Once you stop injecting, your pituitary gland goes right back to normal signaling. It's like turning off a light switch, not permanent damage.
What if I accidentally skip a dose?
Take it as soon as you remember if it's the same day. If you miss a whole day and are already at risk of ovulation, call your clinic immediately. They may adjust your retrieval timing or add another dose. Don't just skip doses without asking your doctor.
Can I use cetrorelix if I'm overweight or have PCOS?
Yes, absolutely. Women with PCOS often benefit from cetrorelix because it gives better control when your ovaries tend to be extra responsive. Your doctor may adjust the dose or timing, but it's a safe choice for higher responders.
How much does cetrorelix cost?
Costs vary, but a typical IVF cycle with cetrorelix injections runs $200-800 depending on how many doses you need. Insurance sometimes covers it because it's FDA-approved for IVF. Ask your clinic about pricing and financial assistance programs.
What if I'm allergic to the injection?
True allergies to cetrorelix are rare, but if you get hives, swelling, or trouble breathing, go to the ER immediately. Minor redness at the injection site is normal and not an allergy. Talk to your doctor about any reactions.
Further reading
History & related research
History · since 1995
The game-changing antagonist that stops the hormone surge instantly instead of causing a dangerous flare
Cetrorelix is a revolutionary peptide drug that blocks GnRH, a master control hormone. Unlike older agonist drugs, cetrorelix works immediately without an initial hormone surge.
Read the full history of CetrorelixReady for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Cetrorelix, on one page.